Showing results (1161-1170 of 8,959) with videos related to
Sort By:
Pageof 896
Journal of Hepatology|December 14, 2024
Impact of metabolism-disrupting chemicals and folic acid supplementation on liver injury and steatosis in mother-child pairsSandra India-Aldana, Vishal Midya, Larissa Betanzos-Robledo, et al.Journal of Hepatology|December 15, 2024
All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver diseaseShang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, et al.Journal of Hepatology|November 22, 2024
Real-world clinical data-driven modelling on the initiation time of antiviral prophylaxis among pregnant women with chronic hepatitis B infectionMingwang Shen, Shihao He, Naijuan Yao, et al.Journal of Hepatology|November 10, 2024
Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver diseaseHyun Young Kim, Sara Brin Rosenthal, Xiao Liu, et al.Journal of Hepatology|October 3, 2024
Plasma exchange does not improve overall survival in patients with acute liver failure in a real-world cohortLaura Burke, William Bernal, Tasneem Pirani, et al.Journal of Hepatology|September 20, 2024
Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trialElton Dajti, Càndid Villanueva, Annalisa Berzigotti, et al.Journal of Hepatology|October 24, 2024
Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistanceSunjae Lee, Bethlehem Arefaine, Neelu Begum, et al.Journal of Hepatology|October 18, 2024
A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver diseaseQingxia Huang, Sami F Qadri, Hua Bian, et al.Journal of Hepatology|November 3, 2024
Blood markers for type-1, -2, and -3 inflammation are associated with severity of acutely decompensated cirrhosisZhujun Cao, Yujing Yao, Minghao Cai, et al.Journal of Hepatology|February 20, 2025
A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancerJennifer J Knox, Mairéad G McNamara, Igor S Bazin, et al.Pageof 896